281 related articles for article (PubMed ID: 37845417)
1. Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography.
Kobayashi T; Iwaki M; Nogami A; Kawamura N; Honda Y; Ogawa Y; Imajo K; Yoneda M; Saito S; Nakajima A
J Gastroenterol; 2024 Jan; 59(1):56-65. PubMed ID: 37845417
[TBL] [Abstract][Full Text] [Related]
2. Change in serial liver stiffness measurement by magnetic resonance elastography and outcomes in NAFLD.
Gidener T; Dierkhising RA; Mara KC; Therneau TM; Venkatesh SK; Ehman RL; Yin M; Allen AM
Hepatology; 2023 Jan; 77(1):268-274. PubMed ID: 35642504
[TBL] [Abstract][Full Text] [Related]
3. Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study.
Ebrahimi F; Hagström H; Sun J; Bergman D; Shang Y; Yang W; Roelstraete B; Ludvigsson JF
J Hepatol; 2023 Dec; 79(6):1374-1384. PubMed ID: 37647992
[TBL] [Abstract][Full Text] [Related]
4. Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B.
Con D; Tu S; Clayton-Chubb D; Lubel JS; Nicoll AJ; Sawhney R; Bloom S
Dig Dis Sci; 2024 Apr; 69(4):1496-1506. PubMed ID: 38376788
[TBL] [Abstract][Full Text] [Related]
5. Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
Lin H; Lee HW; Yip TC; Tsochatzis E; Petta S; Bugianesi E; Yoneda M; Zheng MH; Hagström H; Boursier J; Calleja JL; Goh GB; Chan WK; Gallego-Durán R; Sanyal AJ; de Lédinghen V; Newsome PN; Fan JG; Castéra L; Lai M; Harrison SA; Fournier-Poizat C; Wong GL; Pennisi G; Armandi A; Nakajima A; Liu WY; Shang Y; de Saint-Loup M; Llop E; Teh KK; Lara-Romero C; Asgharpour A; Mahgoub S; Chan MS; Canivet CM; Romero-Gomez M; Kim SU; Wong VW;
JAMA; 2024 Apr; 331(15):1287-1297. PubMed ID: 38512249
[TBL] [Abstract][Full Text] [Related]
6. The associations between fibrosis changes and liver-related events in patients with metabolic dysfunction-associated steatotic liver disease.
Lee HW; Kim KH; Ahn SH; Lee HC; Choi J
Liver Int; 2024 Mar; ():. PubMed ID: 38488679
[TBL] [Abstract][Full Text] [Related]
7. Machine-learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD-related liver fibrosis.
Fan R; Yu N; Li G; Arshad T; Liu WY; Wong GL; Liang X; Chen Y; Jin XZ; Leung HH; Chen J; Wang XD; Yip TC; Sanyal AJ; Sun J; Wong VW; Zheng MH; Hou J
Liver Int; 2024 Mar; 44(3):749-759. PubMed ID: 38131420
[TBL] [Abstract][Full Text] [Related]
8. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis.
Singh S; Fujii LL; Murad MH; Wang Z; Asrani SK; Ehman RL; Kamath PS; Talwalkar JA
Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1573-84.e1-2; quiz e88-9. PubMed ID: 23954643
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: A retrospective study.
Gidener T; Yin M; Dierkhising RA; Allen AM; Ehman RL; Venkatesh SK
Hepatology; 2022 Feb; 75(2):379-390. PubMed ID: 34510513
[TBL] [Abstract][Full Text] [Related]
10. Inflammation activity affects liver stiffness measurement by magnetic resonance elastography in MASLD.
Wei X; Qi S; Wei X; Qiu L; Du X; Liu Y; Xu H; Zhao J; Chen S; Zhang J
Dig Liver Dis; 2024 May; ():. PubMed ID: 38744558
[TBL] [Abstract][Full Text] [Related]
11. Severe hepatic steatosis promotes increased liver stiffness in the early stages of metabolic dysfunction-associated steatotic liver disease.
Kumada T; Toyoda H; Ogawa S; Gotoh T; Suzuki Y; Sugimoto K; Yoshida Y; Kuroda H; Kamada Y; Sumida Y; Ito T; Akita T; Tanaka J
Liver Int; 2024 Apr; ():. PubMed ID: 38558221
[TBL] [Abstract][Full Text] [Related]
12. A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.
Duman S; Kuru D; Gumussoy M; Kiremitci S; Gokcan H; Ulas B; Ellik Z; Ozercan M; Er RE; Karakaya F; Bodakci E; Erden A; Elhan AH; Savas B; Loomba R; Idilman R
Eur Radiol; 2023 Nov; ():. PubMed ID: 37987833
[TBL] [Abstract][Full Text] [Related]
13. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease.
Petta S; Sebastiani G; Viganò M; Ampuero J; Wai-Sun Wong V; Boursier J; Berzigotti A; Bugianesi E; Fracanzani AL; Cammà C; Enea M; Grottes MD; Di Marco V; Younes R; Keyrouz A; Mazzola S; Mendoza Y; Pennisi G; Romero-Gomez M; Craxì A; de Ledinghen V
Clin Gastroenterol Hepatol; 2021 Apr; 19(4):806-815.e5. PubMed ID: 32621970
[TBL] [Abstract][Full Text] [Related]
14. Natural history of metabolic dysfunction-associated steatotic liver disease.
Lekakis V; Papatheodoridis GV
Eur J Intern Med; 2024 Apr; 122():3-10. PubMed ID: 37940495
[TBL] [Abstract][Full Text] [Related]
15. Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis.
Wang JH; Chuah SK; Lu SN; Hung CH; Kuo CM; Tai WC; Chiou SS
Liver Int; 2014 Oct; 34(9):1340-8. PubMed ID: 24620731
[TBL] [Abstract][Full Text] [Related]
16. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality.
Higuchi M; Tamaki N; Kurosaki M; Inada K; Kirino S; Yamashita K; Hayakawa Y; Osawa L; Takaura K; Maeyashiki C; Kaneko S; Yasui Y; Takahashi Y; Tsuchiya K; Nakanishi H; Itakura J; Loomba R; Enomoto N; Izumi N
Aliment Pharmacol Ther; 2022 Feb; 55(3):292-301. PubMed ID: 34927277
[TBL] [Abstract][Full Text] [Related]
18. Improvement in enhanced liver fibrosis score and liver stiffness measurement reflects lower risk of hepatocellular carcinoma.
Liang LY; Wong VW; Tse YK; Yip TC; Lui GC; Chan HL; Wong GL
Aliment Pharmacol Ther; 2019 Jun; 49(12):1509-1517. PubMed ID: 31025388
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance elastography can predict development of hepatocellular carcinoma with longitudinally acquired two-point data.
Ichikawa S; Motosugi U; Enomoto N; Onishi H
Eur Radiol; 2019 Feb; 29(2):1013-1021. PubMed ID: 30043162
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study.
Adler M; Larocca L; Trovato FM; Marcinkowski H; Pasha Y; Taylor-Robinson SD
HPB (Oxford); 2016 Aug; 18(8):678-83. PubMed ID: 27485062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
